#masitinib

Hasil Riset : Masitinib Potensial Sebagai Antikanker Pankreas

Majalah Farmasetika – Artikel penelitian yang baru-baru ini dipublikasikan dan ditinjau oleh sejawat ilmuwan menyimpulkan bahwa penghambatan sel mast dengan masitinib AB Science dapat mewakili pendekatan antiangiogenetik baru pada kanker pankreas. Terapi antiangiogenik mengurangi pertumbuhan pembuluh darah baru yang dibutuhkan tumor untuk tumbuh dan bermetastasis. Masitinib adalah inhibitor…

Masitinib - Successful Phase III clinical trial in first-line advanced pancreatic cancer #masitinib #pancreatictumor #drugtrials #phase3trials #clinicaltrials

AB Science announces successful Phase III clinical trial with masitinib in first-line advanced pancreatic cancer. A lack of effective therapies in the advanced stages of pancreatic cancer makes it one of the most difficult oncology indications to manage, resulting in high mortality rates. Considerable clinical development efforts have been focused on identifying drugs with novel mechanisms of…

Jan 4 (Reuters) – AB SCIENCE SA: * REG-AB SCIENCE ANNOUNCES THAT BASED ON INTERIM ANALYSIS, IDMC RECOMMENDED THE CONTINUATION OF THE MASITINIB PHASE 3 STUDY IN PROGRESSIVE MULTIPLE SCLEROSIS WITH NO REQUIREMENT TO INCREASE THE SAMPLE SIZE * ‍FINAL RESULTS OF STUDY ARE EXPECTED IN Q2 2019​ * ‍IDMC DID NOT REPORT ANY SAFETY CONCERN WITH MASITINIB IN STUDY POPULATION​ Source text for Eikon: Further…

Global Masitinib Market 2017- Eli Lilly and Company, Taiho Pharmaceutical, Bristol-Myers Squibb

The Report entitled Global Masitinib Market2017 analyses the important factors of the Masitinib market based on present industry situations, market demands, business strategies utilized by Masitinib market players and their growth synopsis. This report divides the Masitinib market based on the key players, Type (product Type ), Application (Product Application ) and Regions. High Use of Masitinib…

Masitinib Masitinib; 790299-79-5; Masivet; AB1010; AB-1010; CLASS:Immunomodulator TARGET:KIT (a stem cell factor, also called c-KIT) receptor as well as select other tyrosine kinases STATUS FOR MS:Phase III COMMERCIAL:Under development by AB Science..Ab Science 4-((4-Methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamide AB 1010 UNII-M59NC4E26P…

Masitinib Masitinib; 790299-79-5; Masivet; AB1010; AB-1010; CLASS:Immunomodulator TARGET:KIT (a stem cell factor, also called c-KIT) receptor as well as select other tyrosine kinases STATUS FOR MS:Phase III COMMERCIAL:Under development by AB Science..Ab Science 4-((4-Methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamide AB 1010 UNII-M59NC4E26P…